Analytic Investors’s AtriCure ATRC Stock Holding History

Analytic Investors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-36,095	Closed	-$679K	–	520
2014 Q1	$679K	Buy	+36,095	New	+$740K	0.01%	410

Other funds holding ATRC

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Analytic Investors's ATRC Position: Q2 2014 in Review

Analytic Investors sold out of AtriCure (ATRC) in Q2 2014, closing a stake of 36,095 shares — an estimated $679K sold.

Analytic Investors first reported a position in ATRC in Q1 2014 and held it in 1 quarter. The position peaked at $679K in Q1 2014. 113 funds tracked by Wall St. Rank hold ATRC as of Q2 2014.

Analytic Investors reported no remaining AtriCure position as of Q2 2014 after selling out during the quarter.
Analytic Investors sold 36,095 AtriCure shares in Q2 2014, an estimated $679K.
Analytic Investors first reported a position in AtriCure in Q1 2014 and held it in 1 quarter.
Analytic Investors's AtriCure position peaked at $679K in Q1 2014.
113 funds tracked by Wall St. Rank held AtriCure as of Q2 2014.

Based on Analytic Investors's 13F filing for Q2 2014, filed 13 Aug 2014.